Related Experiment Videos

Cardiac functional reserve is diminished in growth hormone-deficient adults

Robert Moisey1, Steve Orme, Diane Barker

  • 1Department of Endocrinology, Leeds General Infirmary, Leeds, United Kingdom.

Cardiovascular Therapeutics
|February 12, 2009
PubMed

Insights

Patients with severe growth hormone deficiency (GHD) exhibit impaired cardiac functional reserve during peak exercise. This study reveals reduced cardiac power, chronotropic incompetence, and lower pressure-generating capacity in GHD patients compared to healthy individuals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Exercise Physiology

Background:

  • Severe growth hormone deficiency (GHD) is linked to cardiac changes.
  • Previous studies lack direct evidence of cardiac reserve during peak exercise in GHD.

Purpose of the Study:

  • To test the hypothesis that severe GHD patients have reduced cardiac reserve function compared to healthy controls.
  • To investigate peak cardiac power and cardiorespiratory fitness in severe GHD.

Main Methods:

  • Noninvasive hemodynamic measurements during maximal cardiopulmonary exercise testing.
  • Comparison of 18 severe GHD patients with 18 matched healthy controls.
  • Assessment of peak cardiac power, VO2max, heart rate, and systolic blood pressure.

Main Results:

  • GHD patients showed 15% lower peak cardiac power (4.4 W vs. 5.2 W, P=0.02).
  • Similar aerobic exercise peaks (VO2max) and respiratory exchange ratios were observed.
  • GHD patients had lower chronotropic reserve (peak HR 154 bpm vs. 174 bpm, P=0.001) and impaired pressure-generating capacity (peak SBP 160 mmHg vs. 200 mmHg, P<0.0001).

Conclusions:

  • Severe GHD is associated with significantly impaired cardiac functional reserve.
  • Chronotropic incompetence and reduced pressure-generating capacity contribute to this impairment.
  • Noninvasive assessment confirms reduced cardiac pumping capacity in GHD during exercise.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...